Healthcare | May 09, 2022
Strengthening the access to rare disease treatment in India
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
Upon closing, the Quakertown business will become an independent company called Microsize
He will be responsible for ensuring that every dose of medication that ACG Inspection’s pharmaceutical and nutraceutical partners provide is manufactured and delivered exactly as intended
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA
Subscribe To Our Newsletter & Stay Updated
